BAOBAB : Building large instruments for neuroimaging: from population imaging to ultra-high magnetic fields
News
Stephane ROCHE, PhD, HDR
CTO & Medical director Stephane Roche Researcher, Stéphane ROCHE holds a PhD in Biological and Medical Engineering and is a former University Hospital Assistant of the Grenoble Hospitals. Stéphane ROCHE also holds a Habilitation to Supervise Research. He has worked … Read More
Ludovic de ROCHEFORT, PhD, HDR
Founder and CEO Ludovic de Rochefort has a PhD in medical imaging and holds an habilitation to conduct research. He is a certified LSTI ISO/IEC 27001 Implementer (information security management), and Data Protection Officer (CNIL/PECB DPO competencies, sensitive data processing), … Read More
QSM as an imaging biomarker for Alzheimer’s disease
Quantitative susceptibility mapping as an imaging biomarker for Alzheimer’s disease: The expectations and limitations Yuto Uchida, Hirohito Kan, Keita Sakurai, Kenichi Oishi and Noriyuki Matsukawa Frontiers In Neuroscience, 5 august 2022 Alzheimer’s disease (AD) is the most common type of … Read More
Ihr Partner für Quantitative Susceptibility Mapping in Europa
Ihr Partner für Quantitative Susceptibility Mapping in Europa QSM ist ein innovatives, patentiertes Verfahren, das ursprünglich an der Cornell University im Team von Professor Yi Wang entwickelt wurde und das nun von der US-amerikanischen Gesundheitsbehörde FDA für den Einsatz bei … Read More
Publications
BAOBAB CEA/CNRS
BAOBAB : Building large instruments for neuroimaging: from population imaging to ultra-high magnetic fields
Stephane ROCHE, PhD, HDR
CTO & Medical director Stephane Roche Researcher, Stéphane ROCHE holds a PhD in Biological and Medical Engineering and is a former University Hospital Assistant of the Grenoble Hospitals. Stéphane ROCHE also holds a Habilitation to Supervise Research. He has worked … Read More
Ludovic de ROCHEFORT, PhD, HDR
Founder and CEO Ludovic de Rochefort has a PhD in medical imaging and holds an habilitation to conduct research. He is a certified LSTI ISO/IEC 27001 Implementer (information security management), and Data Protection Officer (CNIL/PECB DPO competencies, sensitive data processing), … Read More
QSM as an imaging biomarker for Alzheimer’s disease
Quantitative susceptibility mapping as an imaging biomarker for Alzheimer’s disease: The expectations and limitations Yuto Uchida, Hirohito Kan, Keita Sakurai, Kenichi Oishi and Noriyuki Matsukawa Frontiers In Neuroscience, 5 august 2022 Alzheimer’s disease (AD) is the most common type of … Read More
Ihr Partner für Quantitative Susceptibility Mapping in Europa
Ihr Partner für Quantitative Susceptibility Mapping in Europa QSM ist ein innovatives, patentiertes Verfahren, das ursprünglich an der Cornell University im Team von Professor Yi Wang entwickelt wurde und das nun von der US-amerikanischen Gesundheitsbehörde FDA für den Einsatz bei … Read More